Maintenance work on the ZORA databases is scheduled for Wednesday 22 May 2019 from 20:00-22:00. During this period ZORA and JDB will not be available. Thank you for your understanding.
Madani, R; Poirier, R; Wolfer, D P; Welzl, H; Groscurth, P; Lipp, H P; Lu, B; El Mouedden, M; Mercken, M; Nitsch, R M; Mohajeri, M H (2006). Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo. Journal of Neuroscience Research, 84(8):1871-1878.
Poirier, R; Wolfer, D P; Welzl, H; Tracy, J; Galsworthy, M J; Nitsch, R M; Mohajeri, M H (2006). Neuronal neprilysin overexpression is associated with attenuation of abeta-related spatial memory deficit. Neurobiology of Disease, 24(3):475-483.
Glatzel, M; Mohajeri, M H; Poirier, R; Nitsch, R M; Schwarz, Petra; Lu, B; Aguzzi, A (2005). No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis. Journal of General Virology, 8(6):1861-1867.
Mohajeri, M H; Kuehnle, K; Li, H; Poirier, R; Tracy, J; Nitsch, R M (2004). Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. FEBS Letters, 562(1-3):16-21.
de Quervain, D J F; Poirier, R; Wollmer, M A; Grimaldi, L M E; Tsolaki, M; Streffer, J R; Hock, C; Nitsch, R M; Mohajeri, M H; Papassotiropoulos, A (2004). Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Human Molecular Genetics, 13(1):47-52.